Skip to main content
Clinical Trials/NCT05061862
NCT05061862
Active, Not Recruiting
N/A

Cardiac Implantable Electronic Device (CIED) Research Study

Medtronic Cardiac Rhythm and Heart Failure9 sites in 2 countries1,000 target enrollmentMarch 6, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Arrhythmias, Cardiac
Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Enrollment
1000
Locations
9
Primary Endpoint
Product Development
Status
Active, Not Recruiting
Last Updated
4 months ago

Overview

Brief Summary

The study is designed to collect data on Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details, and/or patient characteristics to support development of future CIED products and procedures.

Detailed Description

This is a data collection, non-randomized, multi-center study. The study will consist of different cohorts with each cohort being independent from another cohort. Each cohort may have a distinct objective, cohort-specific subject population, procedures, and assessments. The study will follow subjects receiving routine care, who meet all of the inclusion criteria and none of the exclusion criteria.

Registry
clinicaltrials.gov
Start Date
March 6, 2022
End Date
May 1, 2026
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject is at least 18 years of age.
  • Subject is willing and able to provide written informed consent.
  • Subject is willing and able to complete the study procedures and visits for the duration of data collection requirements

Exclusion Criteria

  • Subject is unwilling or unable to comply with study procedures as defined in the protocol.
  • Subject with a medical condition that precludes the patient from participation in the opinion of the investigator.
  • Subject is enrolled in another study that could confound the results of this study, without documented pre-approval from a Medtronic study manager.

Outcomes

Primary Outcomes

Product Development

Time Frame: 3 years

Characterize Cardiovascular Implantable Electronic Device (CIED) information, implant procedure details and/or patient characteristics to support development of future CIED products and procedures.

Study Sites (9)

Loading locations...

Similar Trials